The 2026 Healthtech Messaging Index
Local Infusion
mylocalinfusion.com·scored November 1, 2026
17/38
Invisible
The page is doing some work, but the story isn't landing fast enough. Buyers and AI are both left guessing what makes Local Infusion different.
The AI Recommendation Check
When we asked AI who to recommend for Outpatient infusion therapy centers / alternative site of care for specialty infusion, it named:
Buyer we put in the prompt: Patients seeking specialty infusion therapy, referring physicians, and employers/health plans managing specialty drug costs. Both the buyer and the category were inferred from Local Infusion’s homepage alone. The model had no web access.
Local Infusion was not on the list.
A buyer who asked AI this question got 8 names and moved on. Local Infusion never came up.
We asked AI who it recommends for "Patients seeking specialty infusion therapy, referring physicians, and employers/health plans managing specialty drug costs" looking for "Outpatient infusion therapy centers / alternative site of care for specialty infusion". It named Coram CVS Specialty Infusion Services, Option Care Health, BioScrip, Accredo Health Group, AxelaCare Health Solutions. You did not appear. AI can't recommend what it can't clearly understand.
Overall assessment
Local Infusion's biggest strength is its concrete proof metrics ($40K savings, 98 NPS, 99% adherence) paired with genuine multi-audience ICP clarity ... six buyer segments are each named and addressed. The biggest gap is the complete absence of authority signals and competitive acknowledgment: there are no founder credentials, no named alternatives, anonymous-only testimonials, and no cost-of-inaction framing, which together prevent sophisticated B2B buyers (employers, health systems, payers) from trusting the claims enough to act.
Signal by category
Narrative Clarity
8 signals
Trust Signal
4 signals
AI Signal
6 signals
Conversion Signal
1 signal
Weakest signal · fix this first
05Problem Leadership
“Patient-centered care, powered by people + tech”
The hero leads with the company's solution and philosophy, not the buyer's problem; no articulation of the pain (cost, access barriers, poor experience) before presenting the answer.
All 19 signals, scored 0 to 2.
Total 17/38
Narrative Clarity
8 signals
- 1
01The 7-Second Test
“Outpatient Infusion Therapy Centers / Because patients physicians employers health systems pharma payers you deserve better.”
The category is clear (outpatient infusion therapy) but the rotating 'you deserve better' tagline is vague and doesn't articulate the specific problem solved or a distinct point of view in 7 seconds.
- 1
02Rebellion / Movement
“remove obstacles between patients and better health”
There's an implied enemy (friction, obstacles) but no named status quo, no named competitor pattern (e.g., hospital outpatient departments overcharging), and no explicit rebellion framing.
- 1
03Owned Language & Category
“Specialty infusion, without the friction" and "Infusion Guide”
'Infusion Guide' is a mildly owned term and 'without the friction' hints at a frame, but neither is developed into a named category or citable framework an AI would quote back.
- 2
04ICP Clarity
“patients / physicians / employers / health systems / pharma / payers" with dedicated sub-sections for each”
Every major buyer segment is explicitly named and linked to a dedicated page, making it immediately clear whether you're the intended audience.
- 0
05Problem Leadershipweakest
“Patient-centered care, powered by people + tech”
The hero leads with the company's solution and philosophy, not the buyer's problem; no articulation of the pain (cost, access barriers, poor experience) before presenting the answer.
- 2
06Solution Clarity
“Outpatient Infusion Therapy Centers" combining "personalized care with our technology platform to remove obstacles between patients and better health”
A visitor can clearly repeat what Local Infusion does: outpatient infusion centers that use technology to make specialty infusion faster, cheaper, and more comfortable.
- 0
07Cost of Inaction
“No mention of consequences of staying with hospital-based infusion or doing nothing anywhere on the page.”
The page never names what happens if a patient, employer, or payer doesn't switch ... no lost money quantified as a warning, no clinical risk cited as a cost of inaction.
- 1
08Promised Land
“Lower costs, happier employees" and "$40K average annual savings per patient”
There's a numeric promised land for cost savings but no vivid, specific 'after' narrative describing life post-treatment or post-switch for each buyer; it stays at the slogan level.
Trust Signal
4 signals
- 2
09Proof & Evidence
“$40K Average annual savings per patient" / "98 NPS" / "99% Medication & care plan adherence”
Three concrete, specific metrics are stated; these are actual numbers, not adjectives, and they anchor the value proposition credibly.
- 1
10Social Proof
“Local Infusion Patient / North Carolina" (repeated pattern ... no names, titles, or companies)”
Testimonials are present and emotionally strong, but every single one is anonymous ('Local Infusion Patient'), stripping them of the credibility that names, titles, and employers would provide.
- 0
11Authority & Credibility
“No founder credentials, original research, frameworks, awards, publications, or named clinical leadership anywhere on the page.”
Authority is completely absent; there is no demonstration of who built this or why they are credible in specialty infusion beyond asserting they follow safety protocols.
- 0
12Alternatives Acknowledged
“No mention of hospital outpatient departments, home infusion, competitor names, or 'do nothing' option anywhere on the page.”
The page never acknowledges that buyers have alternatives; it ignores the comparison set entirely, which weakens trust for sophisticated B2B buyers.
AI Signal
6 signals
- 2
13Customer Focus
“A place you actually want to be" / "What stands out most is that you are treated like a person, not just another patient”
The customer is the consistent protagonist: sections are organized by audience role, testimonials center patient experience, and copy addresses 'you' throughout.
- 1
14AI-Parmesan Index
“Our AI-driven platform works behind the scenes to coordinate care and manage prior authorizations”
AI is mentioned once with a specific use case (prior auth coordination), which is better than empty claims, but it's a single vague sentence with no mechanism detail ... not zero but not substantive enough for a 2.
- 1
15LLM Quotability
“$40K Average annual savings per patient" / "99% Medication & care plan adherence" / "98 NPS”
The stats are quotable in isolation but lack source attribution, methodology context, or narrative sentences an LLM could lift as a recommendation; they need a frame like 'compared to hospital outpatient settings.'
- 0
16Copyright Freshness
“Image URLs contain '/2026/09/' but no visible blog posts, case study dates, or copyright year are present in the scraped content.”
There are no visible dated content pieces or copyright year on the page, eliminating recency signals that AI engines weight for freshness.
- 1
17Entity Distinctiveness
“dedicated Infusion Guide" / "reach out to patients within hours" / "digital onboarding takes <2 minutes by text”
A few distinctive operational details exist (Infusion Guide role, 2-minute text onboarding) but the overall positioning ... comfortable outpatient infusion, lower cost, tech-enabled ... is largely replicable by any competitor in the space.
- 0
18AI Recommendation Check
“AI's picks: Coram CVS Specialty Infusion Services, Option Care Health, BioScrip, Accredo Health Group, AxelaCare Health Solutions, Ambulatory Infusion Centers (AIC). You were not named.”
We asked AI who it recommends for "Patients seeking specialty infusion therapy, referring physicians, and employers/health plans managing specialty drug costs" looking for "Outpatient infusion therapy centers / alternative site of care for specialty infusion". It named Coram CVS Specialty Infusion Services, Option Care Health, BioScrip, Accredo Health Group, AxelaCare Health Solutions. You did not appear. AI can't recommend what it can't clearly understand.
Conversion Signal
1 signal
- 1
19Path & CTA Clarity
“Get started" CTA in hero; "Download provider forms" for physicians; no visible numbered process steps on the homepage.”
There are multiple CTAs but no clearly numbered path connecting a process to a primary CTA and a soft secondary ... the 'How it Works' section describes features, not a step-by-step buyer journey.
Your move
Think Local Infusion’s score is wrong? Good. Let’s look at it together.
Twenty minutes with Greg. Bring the page, bring the argument. You’ll leave knowing exactly which signal is costing Local Infusion the AI recommendation, and what to write instead.
Not on the list? Run your homepage through the free Brand Signal Score and see where you’d land. Same 19 signals, same AI check, two minutes.